Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
25,861,339
-
Shares change
-
-511,052
-
Total reported value, excl. options
-
$110,939,345
-
Value change
-
-$1,933,801
-
Number of buys
-
33
-
Number of sells
-
34
-
Price
-
$4.29
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2020
As of 31 Dec 2020 HARVARD BIOSCIENCE INC - Common Stock (HBIO) had 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,861,339 shares of stock of the company.
Largest 10 holders included BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., GRANAHAN INVESTMENT MANAGEMENT INC/MA, Portolan Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, and Harvey Partners, LLC.
This table shows 80 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.